EA Pharma Co., Ltd.
13 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants (NCT04223960) | EA Pharma Co., Ltd. | 2020-01-09 |
| A Study of E6011 in Participants With Active Crohn's Disease (NCT03733314) | EA Pharma Co., Ltd. | 2019-04-25 |
| A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants (NCT03922633) | EA Pharma Co., Ltd. | 2019-04-22 |
| A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis (NCT03531892) | EA Pharma Co., Ltd. | 2018-06-06 |
| A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants (NCT03444818) | EA Pharma Co., Ltd. | 2018-04-17 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Male Participants (NCT03390647) | EA Pharma Co., Ltd. | 2017-12-21 |
Track EA Pharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.